Filing Details
- Accession Number:
- 0000885590-12-000029
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-14 18:57:28
- Reporting Period:
- 2012-05-14
- Filing Date:
- 2012-05-14
- Accepted Time:
- 2012-05-14 17:57:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885590 | Valeant Pharmaceuticals International Inc. | VRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1190966 | E Laurence Paul | 4787 Levy Street Montreal A8 H4R 2P9 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, No Par Value | Acquisiton | 2012-05-14 | 2,100 | $51.03 | 34,497 | No | 4 | P | Direct | |
Common Stock, No Par Value | Acquisiton | 2012-05-14 | 2,900 | $51.03 | 37,397 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- This number represents common shares purchased by the officer, as well as other outstanding equity awards that were previously reported in Table 1.